Answer
It is a targeted tyrosine kinase inhibitor rather than conventional cytotoxic chemotherapy. It blocks VEGF receptors involved in tumour blood-vessel formation.
Sources for this answer
- FRUZAQLA 1 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.